151 related articles for article (PubMed ID: 2491889)
1. Antiinflammatory 2,6-di-tert-butyl-4-(2-arylethenyl)phenols.
Lazer ES; Wong HC; Possanza GJ; Graham AG; Farina PR
J Med Chem; 1989 Jan; 32(1):100-4. PubMed ID: 2491889
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
[TBL] [Abstract][Full Text] [Related]
3. Effect of structure on potency and selectivity in 2,6-disubstituted 4-(2-arylethenyl)phenol lipoxygenase inhibitors.
Lazer ES; Wong HC; Wegner CD; Graham AG; Farina PR
J Med Chem; 1990 Jul; 33(7):1892-8. PubMed ID: 2113949
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)- 4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity.
Unangst PC; Connor DT; Cetenko WA; Sorenson RJ; Kostlan CR; Sircar JC; Wright CD; Schrier DJ; Dyer RD
J Med Chem; 1994 Jan; 37(2):322-8. PubMed ID: 8295221
[TBL] [Abstract][Full Text] [Related]
6. The in vivo antiinflammatory effects of (E)-2,6-bis(1,1-dimethyl-ethyl)-4-[2-(5-methyl-1H-pyrazol-3-yl)ethenyl ] phenol (PD 127443) a novel dual inhibitor of 5-lipoxygenase and cyclooxygenase.
Schrier DJ; Adamchak MA; Boctor AM; Kostlan CR; Flynn DL; Jordan JH; Lesch ME; Okonkwo GC
Agents Actions; 1989 Jun; 27(3-4):391-4. PubMed ID: 2552768
[No Abstract] [Full Text] [Related]
7. Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.
Inagaki M; Tsuri T; Jyoyama H; Ono T; Yamada K; Kobayashi M; Hori Y; Arimura A; Yasui K; Ohno K; Kakudo S; Koizumi K; Suzuki R; Kawai S; Kato M; Matsumoto S
J Med Chem; 2000 May; 43(10):2040-8. PubMed ID: 10821716
[TBL] [Abstract][Full Text] [Related]
8. Antiarthritic profile of BF-389--a novel anti-inflammatory agent with low ulcerogenic liability.
Wong S; Lee SJ; Frierson MR; Proch J; Miskowski TA; Rigby BS; Schmolka SJ; Naismith RW; Kreutzer DC; Lindquist R
Agents Actions; 1992 Sep; 37(1-2):90-8. PubMed ID: 1456184
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
Moreau A; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
[TBL] [Abstract][Full Text] [Related]
10. Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors.
Unangst PC; Shrum GP; Connor DT; Dyer RD; Schrier DJ
J Med Chem; 1992 Oct; 35(20):3691-8. PubMed ID: 1433181
[TBL] [Abstract][Full Text] [Related]
11. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.
Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Chen J; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
J Med Chem; 1998 Aug; 41(18):3515-29. PubMed ID: 9719605
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiinflammatory activity of coumarin derivatives.
Kontogiorgis CA; Hadjipavlou-Litina DJ
J Med Chem; 2005 Oct; 48(20):6400-8. PubMed ID: 16190766
[TBL] [Abstract][Full Text] [Related]
13. Studies on the synthesis and anti-inflammatory activity of 2,6-di-tert-butylphenols with a heterocyclic group at the 4-position. I.
Isomura Y; Ito N; Homma H; Abe T; Kubo K
Chem Pharm Bull (Tokyo); 1983 Sep; 31(9):3168-78. PubMed ID: 6607781
[No Abstract] [Full Text] [Related]
14. Studies on the synthesis and anti-inflammatory activity of 2,6-di-tert-butylphenols with a heterocyclic group at the 4-position. II.
Isomura Y; Ito N; Sakamoto S; Homma H; Abe T; Kubo K
Chem Pharm Bull (Tokyo); 1983 Sep; 31(9):3179-85. PubMed ID: 6607782
[No Abstract] [Full Text] [Related]
15. Substituted 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-ones as potential antiinflammatory agents.
Ting PC; Kaminski JJ; Sherlock MH; Tom WC; Lee JF; Bryant RW; Watnick AS; McPhail AT
J Med Chem; 1990 Oct; 33(10):2697-706. PubMed ID: 2145433
[TBL] [Abstract][Full Text] [Related]
16. Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agents.
Mullican MD; Wilson MW; Connor DT; Kostlan CR; Schrier DJ; Dyer RD
J Med Chem; 1993 Apr; 36(8):1090-9. PubMed ID: 8478906
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of the antiinflammatory activity of N-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)-4-oxo-thiazolidin-3-yl]-nicotinamide.
Kalia R; Rao CM; Kutty NG
Arzneimittelforschung; 2007; 57(9):616-22. PubMed ID: 17966761
[TBL] [Abstract][Full Text] [Related]
18. 4-Hydroxy-3-quinolinecarboxamides with antiarthritic and analgesic activities.
Clemence F; Le Martret O; Delevallee F; Benzoni J; Jouanen A; Jouquey S; Mouren M; Deraedt R
J Med Chem; 1988 Jul; 31(7):1453-62. PubMed ID: 3133478
[TBL] [Abstract][Full Text] [Related]
19. Studies on styrene derivatives. II. Synthesis and antiinflammatory activity of 3,5-di-tert-butyl-4-hydroxystyrenes.
Katsumi I; Kondo H; Fuse Y; Yamashita K; Hidaka T; Hosoe K; Takeo K; Yamashita T; Watanabe K
Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1619-27. PubMed ID: 3719863
[No Abstract] [Full Text] [Related]
20. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
